stockrow
Saturday 7 November 2026
Export ODTX’s income statement to Excel — free account
Odyssey Therapeutics, Inc.
ODTX Healthcare Biotechnology
19.13
0.25
+1.32%
Follow ODTX
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
|
+3 more TTM periods Free account |
— | 0.00% | 0.00% | 0.00% | |
| — | 0.00% | (69.34%) | 0.00% | ||
ROIC |
0.00% | (2,416.69%) | (99.09%) | (238.81%) | |
Return on Tangible Assets |
0.00% | (90.53%) | (56.28%) | (56.77%) | |
Free Cash Flow per Share |
— | (25.81) | (4.65) | (3.10) | |
Free Cash Flow |
— | (145.97) | (140.89) | (148.71) | |
Capital Expenditures |
— | (0.79) | 0.17 | (0.36) | |
| Other line items | |||||
Cash ROIC |
0.00% | (41.05%) | (19.25%) | (21.19%) | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
— | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
— | (10,607.67) | (5,315.91) | (4,422.60) | |
Operating CF/Net income |
— | 0.95 | 0.84 | 0.83 | |
Depreciation/Fixed assets |
0.00 | 0.75 | 0.96 | 0.95 | |
Capex/Depreciation |
— | (0.16) | 0.04 | (0.08) | |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
— | (25.67) | (4.66) | (3.09) | |
Capex per Share |
— | (0.14) | 0.01 | (0.01) | |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 6 Nov 2026